Sonic Healthcare Limited
SHL
Classificação em ações
#2850
Sonic Healthcare Limited delivers medical diagnostic services to a diverse... Sonic Healthcare Limited delivers medical diagnostic services to a diverse clientele, including medical professionals, hospitals, public health organizations, and individual patients. The company's services encompass a broad spectrum of laboratory medicine and pathology testing, covering biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal diagnostics, toxicology, and other related functions. Furthermore, Sonic provides extensive radiology services, such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. Its offerings also extend to primary care medical services, featuring general practice clinics, occupational health, specialized skin cancer clinics, after-hours GP services, IT solutions for general practices, and various community-based healthcare programs. Operating internationally, the company has a significant presence in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, and Belgium. Founded in 1934, Sonic Healthcare Limited is headquartered in Sydney, Australia.
Preço da ação
$13.18
Valor de mercado
$6.51B
Variação (1 dia)
-0.21%
Variação (1 ano)
-5.73%
País
AU
Negociar Sonic Healthcare Limited (SHL)
Categoria
Healthcare
Receita da Sonic Healthcare Limited (SHL)
Receita em Jun 2026 TTM: $7.72B
De acordo com os últimos relatórios financeiros da Sonic Healthcare Limited, a receita atual da empresa (TTM) é $7.72B. Em 2024, a empresa obteve uma receita de $5.97B um aumento em relação a a receita do ano 2023, que foi de $5.43B. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Sonic Healthcare Limited de 2000 a 2026
Receita no final de cada ano
| Ano | Receita | Alterar |
|---|---|---|
| 2026 (TTM) | $7.72B | 21.62% |
| 2025 | $6.35B | 6.44% |
| 2024 | $5.97B | 9.92% |
| 2023 | $5.43B | -15.46% |
| 2022 | $6.42B | -2.19% |
| 2021 | $6.56B | 44.93% |
| 2020 | $4.53B | 5.12% |
| 2019 | $4.31B | 6.21% |
| 2018 | $4.06B | 4.22% |
| 2017 | $3.89B | 5.59% |
| 2016 | $3.69B | 15.59% |
| 2015 | $3.19B | -12.32% |
| 2014 | $3.64B | 16.17% |
| 2013 | $3.13B | -7.83% |
| 2012 | $3.40B | 2.73% |
| 2011 | $3.31B | 31.31% |
| 2010 | $2.52B | 4.80% |
| 2009 | $2.40B | 7.41% |
| 2008 | $2.24B | 42.62% |
| 2007 | $1.57B | 29.80% |
| 2006 | $1.21B | 16.78% |
| 2005 | $1.03B | 45.21% |
| 2004 | $712.48M | 10.16% |
| 2003 | $646.79M | 35.18% |
| 2002 | $478.47M | 51.42% |
| 2001 | $315.99M | 0.00% |
| 2000 | 0.00 | 0.00% |
Receita de empresas similares ou concorrentes
| Empresa | Receita | Diferença de Receita | País |
|---|---|---|---|
| $46.34B | 499.99% |
US
|
|
| $25.11B | 225.10% |
US
|
|
| $2.71B | -64.95% |
US
|
|
| - | - |
CN
|
|
| $7.37B | -4.54% |
US
|
